Inspirna
inspirna.com
Actively hiring
Biotechnology
Health Care
Oncology Therapeutics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$133.9M
4 rounds on record
Latest round
$55.1M
Venture round · Jun 2022 · 4 yr ago
Team
17
US Form 5500 (plan participants) · Dec 2024
Backers
1
Sofinnova Partners
The money's age
Long since its last round
51 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 21, 2024
New executive Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D. · inspirna.com
Jan 3, 2024
Partnership Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid (RGX-202) · businesswire.com
May 1, 2023
New executive Inspirna Appoints Dr. Usman "Oz" Azam, M.D., as New Chief Executive Officer · inspirna.com
Jun 24, 2022
Raised a round Venture round $55.1M · SEC Form D
Feb 12, 2021
Raised a round Venture round $6M · SEC Form D
Sep 27, 2018
Raised a round Venture round $39.8M · SEC Form D
Jun 3, 2016
Raised a round Venture round $33M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2022 | $55.1M | — | SEC Form D |
| Venture round | Feb 2021 | $6M | — | SEC Form D |
| Venture round | Sep 2018 | $39.8M | — | SEC Form D |
| Venture round | Jun 2016 | $33M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Inspirna, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Eric RowinskyDirectorSEC Form D
Masoud TavazoieExecutive Officer, DirectorSEC Form D
David DarstExecutive OfficerSEC Form D
Saeed TavazoieExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Sofinnova Partners Similar startupsby what they do, their industry and backers
Transform Your Supply Chain with confidence, Not Guesswork Zero100 gives Chief Supply Chain Officers and Chief Operations Officers the…
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
What if we made as many cancer drugs next year as we have in the last decade?
A comprehensive platform for care that happens between visits, Canopy enhances patient care, improves clinical workflows, and generates new…
News
Inspirna Leaving Manhattan for 7K-SF of Lab Space in Queens
Laboratory robotics firm Opentrons has agreed to sublease 7,302 square feet at the Alexandria Center for Life Science in Long Island City.
Read more
Report
Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D.
NEW YORK - May 21st, 2024 - Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class cancer therapeutics, announced today the appointment of Karim Benhadji, M.D., as Chief Medical Officer, effective May 1, 2024. Dr. Benhadji wi
Read more
Report
Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
New York, NY - January 4, 2024 - Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class cancer therapeutics, announced today that Chief Executive Officer Dr. Usman "Oz" Azam, M.D., will participate in a corporate presentation
Read more
Report
Pro access
Upgrade to see all 21 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Eric Rowinsky
Director
Masoud Tavazoie
Executive Officer, Director
David Darst
Executive Officer
Saeed Tavazoie
Executive Officer, Director
Dieter Weinand
Director
Jue Pu
Director
Raymond Camahort
Director
Jack Nielsen
Director
Antoine Papiernik
Director
Peter Van Vlasselaer
Director
Michael Ginder
Director
Nancy Chang
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
New York
United States
HQ
Translational and Clinical Development Strategies for IO Agents Targeting the Innate Immune System
Immuno-Oncology 360° | Crown Plaza Time Square, New York City | February 6, 2019 Masoud Tavazoie, Rgenix CEO… Read More
Long Island City
United States
Regional office
30-02 48th Ave, Ste 350
30-02 48th Ave, Ste 350, Long Island City, NY 11101